Grow Brian has filed 30 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 11887 shares of Organogenesis Holdings Inc. ($ORGO) on February 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 11887 | $3.84 | 899,724.0000 | 130,848,995 | 1.30% | 0.01% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Class A Common Stock | 48818 | $0.00 | 911,611.0000 | 130,848,995 | 5.66% | 0.04% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Class A Common Stock | 234375 | $0.00 | 862,793.0000 | 130,848,995 | 37.30% | 0.18% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Stock Option (Right to Buy) | 133630 | $0.00 | 133,630.0000 | 130,848,995 | 9999.99% | 0.10% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 11768 | $3.84 | 899,355.0000 | 130,848,995 | 1.29% | 0.01% |
| Feb. 18, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Class A Common Stock | 48330 | $0.00 | 911,123.0000 | 130,848,995 | 5.60% | 0.04% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 11144 | $3.73 | 628,418.0000 | 130,848,995 | 1.74% | 0.01% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 18910 | $3.73 | 650,121.0000 | 130,848,995 | 2.83% | 0.01% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 3346 | $3.73 | 669,031.0000 | 130,848,995 | 0.50% | 0.00% |
| Feb. 15, 2026 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 10559 | $3.73 | 639,562.0000 | 130,848,995 | 1.62% | 0.01% |
| Aug. 11, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | M | Class A Common Stock | 4060 | $2.47 | 674,550.0000 | 133,926,755 | 0.61% | 0.00% |
| Aug. 11, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 2173 | $4.62 | 672,377.0000 | 133,926,755 | 0.32% | 0.00% |
| Aug. 11, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | M | Stock Option (Right to Buy) | 4060 | $0.00 | 0.0000 | 133,926,755 | 100.00% | 0.00% |
| Feb. 19, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Stock Option (Right to Buy) | 189369 | $0.00 | 189,369.0000 | 131,673,278 | 9999.99% | 0.14% |
| Feb. 19, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Class A Common Stock | 183067 | $0.00 | 670,490.0000 | 131,673,278 | 37.56% | 0.14% |
| Feb. 15, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 10559 | $3.70 | 510,250.0000 | 131,673,278 | 2.03% | 0.01% |
| Feb. 16, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 656 | $3.70 | 487,423.0000 | 131,673,278 | 0.13% | 0.00% |
| Feb. 15, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 19423 | $3.70 | 490,827.0000 | 131,673,278 | 3.81% | 0.01% |
| Feb. 15, 2025 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 2748 | $3.70 | 488,079.0000 | 131,673,278 | 0.56% | 0.00% |
| April 1, 2024 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 1977 | $2.80 | 520,809.0000 | 132,746,727 | 0.38% | 0.00% |
| Feb. 21, 2024 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Stock Option (Right to Buy) | 313636 | $0.00 | 313,636.0000 | 132,746,727 | 9999.99% | 0.24% |
| Feb. 21, 2024 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Class A Common Stock | 173469 | $0.00 | 522,786.0000 | 132,746,727 | 49.66% | 0.13% |
| Feb. 16, 2024 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 799 | $3.48 | 349,317.0000 | 132,746,727 | 0.23% | 0.00% |
| Feb. 15, 2024 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 18738 | $3.68 | 353,462.0000 | 132,746,727 | 5.03% | 0.01% |
| Feb. 15, 2024 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 3346 | $3.68 | 350,116.0000 | 132,746,727 | 0.95% | 0.00% |
| April 1, 2023 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 2408 | $2.13 | 372,200.0000 | 132,383,152 | 0.64% | 0.00% |
| Feb. 22, 2023 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Stock Option (Right to Buy) | 345470 | $0.00 | 345,470.0000 | 132,383,152 | 9999.99% | 0.26% |
| Feb. 22, 2023 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | A | Class A Common Stock | 291009 | $0.00 | 374,608.0000 | 132,383,152 | 348.10% | 0.22% |
| Feb. 15, 2023 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 3346 | $2.92 | 84,398.0000 | 132,383,152 | 3.81% | 0.00% |
| Feb. 16, 2023 | Organogenesis Holdings Inc. | $ORGO | Grow Brian | Chief Commercial Officer | F | Class A Common Stock | 799 | $2.75 | 83,599.0000 | 132,383,152 | 0.95% | 0.00% |